Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced the closing of the $25M final tranche to its Series B ...
Delivering strong industry turnout, dynamic sales, and shoppable experiencesunder the theme "Crossroads"HONG KONG, Dec. 23, ...
With AI-powered voice and video deepfakes on the rise, Adaptive Security has raised $81 million in a Bain Capital ...
The music industry's uptake of AI complicates the boundaries between listener, artist and music in troubling new ways, argues ...
For millions of developers and AI enthusiasts, the mechanics behind ChatGPT’s "memory" have long been assumed to be a ...
We’ve all seen it. The “Frankenstein UI.” You grab a “home” icon from one open-source set, a “settings” cog from a different ...
Arabian Post on MSN
SVG trickery exposes deeper clickjacking threat
A newly documented exploitation method using scalable vector graphics has intensified scrutiny of browser-level security after a security researcher demonstrated how attackers can transform ...
Walt Disney Animation Studios’ Zootopia 2 has roared past the $1 billion threshold at the global box office, achieving the massive milestone in just 17 days. This phenomenal pace makes it the ...
Rocket Pharmaceuticals (NASDAQ:RCKT) advances gene-therapy innovation and appears in broader discussions involving the nasdaq ...
AAV-based gene therapies hold promise for treating disease, but their long-lasting gene expression limits their use in regenerative medicine. A study now presents DreAM, a drug-inducible AAV system ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Animation isn’t just for kids, and the too-overlooked art form has plenty of merit for viewers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results